Effects of bisphosphonates on appendicular fracture repair in rodents

The balance between osteoclastic bone resorption and osteoblastic bone formation is ultimately responsible for maintaining a structural and functional skeleton. Despite their strength, bones do break and the main cause of fractures are trauma and decreased bone mineral density as a result of aging a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone (New York, N.Y.) N.Y.), 2022-11, Vol.164, p.116542-116542, Article 116542
1. Verfasser: Hadjiargyrou, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 116542
container_issue
container_start_page 116542
container_title Bone (New York, N.Y.)
container_volume 164
creator Hadjiargyrou, Michael
description The balance between osteoclastic bone resorption and osteoblastic bone formation is ultimately responsible for maintaining a structural and functional skeleton. Despite their strength, bones do break and the main cause of fractures are trauma and decreased bone mineral density as a result of aging and/or pathology that weakens the bone's microarchitecture and subsequently, its material properties. Osteoporosis is a disease marked by increased osteoclast activity and decreased osteoblastic activity tipping the remodeling balance in favor of bone resorption and can be caused by aging, glucocorticoids, disuse and estrogen-deficiency. Ultimately, this leads to brittle and weaker bones which become more prone to trauma or stress-induced fractures. The current treatment for preventing and treating osteoporotic fractures is the use of antiresorptive drugs such as bisphosphonates (BPs) and denosumab, but unfortunately, their long-term use, especially with alendronate and ibandronate, has been associated with increased risk of atypical femoral fractures (AFFs); femoral diaphyseal fractures distal to the lesser trochanter but proximal to the supracondylar flare. The purpose of this review is to examine the information that exists in the literature examining the effects of BPs on fracture repair of long bones in rodent (rat and mouse) models. The focus on rodents stems from the scientific community's unresolved need to develop small animal models to examine the molecular, cellular, tissue and biomechanical mechanisms responsible for the development of AFFs and how best they can be treated. •Osteoporosis is a major health care problem.•Long-term use of bisphosphonates has been associated with increased risk of atypical femoral fractures (AFFs).•Multiple rat and mouse studies have been conducted with bisphosphonates and fracture repair.•Results of bisphosphonate use during fracture repair are mixed; some show benefits while other do not.•There is a need for additional studies in small animal models in order to study AFFs.
doi_str_mv 10.1016/j.bone.2022.116542
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2708735764</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S8756328222002198</els_id><sourcerecordid>2708735764</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-3fa9a24f58e2b130806df48dbb17079a4cd41ed5fb8d088fb3c08160591eb2903</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoOI6-gKsu3bTm0jYpuJFhvMCAG12HXE4wQyepSSv49rbUtYvDgcP_Hfg_hG4Jrggm7f2x0jFARTGlFSFtU9MztCGCs5Lylp2jjeBNWzIq6CW6yvmIMWYdJxu03zsHZsxFdIX2efiMywQ1wnwKhRoGCNabqVepcEmZcUpQJBiUT4UPRYoWwpiv0YVTfYabv71FH0_7991LeXh7ft09HkrDOB9L5lSnaO0aAVQThgVurauF1ZpwzDtVG1sTsI3TwmIhnGYGC9LipiOgaYfZFt2tf4cUvybIozz5bKDvVYA4ZUk5njs3vK3nKF2jJsWcEzg5JH9S6UcSLBdn8igXZ3JxJldnM_SwQjCX-PaQZDYeggHr02xJ2uj_w38BIGF1VQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2708735764</pqid></control><display><type>article</type><title>Effects of bisphosphonates on appendicular fracture repair in rodents</title><source>Elsevier ScienceDirect Journals</source><creator>Hadjiargyrou, Michael</creator><creatorcontrib>Hadjiargyrou, Michael</creatorcontrib><description>The balance between osteoclastic bone resorption and osteoblastic bone formation is ultimately responsible for maintaining a structural and functional skeleton. Despite their strength, bones do break and the main cause of fractures are trauma and decreased bone mineral density as a result of aging and/or pathology that weakens the bone's microarchitecture and subsequently, its material properties. Osteoporosis is a disease marked by increased osteoclast activity and decreased osteoblastic activity tipping the remodeling balance in favor of bone resorption and can be caused by aging, glucocorticoids, disuse and estrogen-deficiency. Ultimately, this leads to brittle and weaker bones which become more prone to trauma or stress-induced fractures. The current treatment for preventing and treating osteoporotic fractures is the use of antiresorptive drugs such as bisphosphonates (BPs) and denosumab, but unfortunately, their long-term use, especially with alendronate and ibandronate, has been associated with increased risk of atypical femoral fractures (AFFs); femoral diaphyseal fractures distal to the lesser trochanter but proximal to the supracondylar flare. The purpose of this review is to examine the information that exists in the literature examining the effects of BPs on fracture repair of long bones in rodent (rat and mouse) models. The focus on rodents stems from the scientific community's unresolved need to develop small animal models to examine the molecular, cellular, tissue and biomechanical mechanisms responsible for the development of AFFs and how best they can be treated. •Osteoporosis is a major health care problem.•Long-term use of bisphosphonates has been associated with increased risk of atypical femoral fractures (AFFs).•Multiple rat and mouse studies have been conducted with bisphosphonates and fracture repair.•Results of bisphosphonate use during fracture repair are mixed; some show benefits while other do not.•There is a need for additional studies in small animal models in order to study AFFs.</description><identifier>ISSN: 8756-3282</identifier><identifier>EISSN: 1873-2763</identifier><identifier>DOI: 10.1016/j.bone.2022.116542</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Bisphosphonates ; Fracture repair ; Osteoporosis ; Rodents</subject><ispartof>Bone (New York, N.Y.), 2022-11, Vol.164, p.116542-116542, Article 116542</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-3fa9a24f58e2b130806df48dbb17079a4cd41ed5fb8d088fb3c08160591eb2903</citedby><cites>FETCH-LOGICAL-c377t-3fa9a24f58e2b130806df48dbb17079a4cd41ed5fb8d088fb3c08160591eb2903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Hadjiargyrou, Michael</creatorcontrib><title>Effects of bisphosphonates on appendicular fracture repair in rodents</title><title>Bone (New York, N.Y.)</title><description>The balance between osteoclastic bone resorption and osteoblastic bone formation is ultimately responsible for maintaining a structural and functional skeleton. Despite their strength, bones do break and the main cause of fractures are trauma and decreased bone mineral density as a result of aging and/or pathology that weakens the bone's microarchitecture and subsequently, its material properties. Osteoporosis is a disease marked by increased osteoclast activity and decreased osteoblastic activity tipping the remodeling balance in favor of bone resorption and can be caused by aging, glucocorticoids, disuse and estrogen-deficiency. Ultimately, this leads to brittle and weaker bones which become more prone to trauma or stress-induced fractures. The current treatment for preventing and treating osteoporotic fractures is the use of antiresorptive drugs such as bisphosphonates (BPs) and denosumab, but unfortunately, their long-term use, especially with alendronate and ibandronate, has been associated with increased risk of atypical femoral fractures (AFFs); femoral diaphyseal fractures distal to the lesser trochanter but proximal to the supracondylar flare. The purpose of this review is to examine the information that exists in the literature examining the effects of BPs on fracture repair of long bones in rodent (rat and mouse) models. The focus on rodents stems from the scientific community's unresolved need to develop small animal models to examine the molecular, cellular, tissue and biomechanical mechanisms responsible for the development of AFFs and how best they can be treated. •Osteoporosis is a major health care problem.•Long-term use of bisphosphonates has been associated with increased risk of atypical femoral fractures (AFFs).•Multiple rat and mouse studies have been conducted with bisphosphonates and fracture repair.•Results of bisphosphonate use during fracture repair are mixed; some show benefits while other do not.•There is a need for additional studies in small animal models in order to study AFFs.</description><subject>Bisphosphonates</subject><subject>Fracture repair</subject><subject>Osteoporosis</subject><subject>Rodents</subject><issn>8756-3282</issn><issn>1873-2763</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxDAUhoMoOI6-gKsu3bTm0jYpuJFhvMCAG12HXE4wQyepSSv49rbUtYvDgcP_Hfg_hG4Jrggm7f2x0jFARTGlFSFtU9MztCGCs5Lylp2jjeBNWzIq6CW6yvmIMWYdJxu03zsHZsxFdIX2efiMywQ1wnwKhRoGCNabqVepcEmZcUpQJBiUT4UPRYoWwpiv0YVTfYabv71FH0_7991LeXh7ft09HkrDOB9L5lSnaO0aAVQThgVurauF1ZpwzDtVG1sTsI3TwmIhnGYGC9LipiOgaYfZFt2tf4cUvybIozz5bKDvVYA4ZUk5njs3vK3nKF2jJsWcEzg5JH9S6UcSLBdn8igXZ3JxJldnM_SwQjCX-PaQZDYeggHr02xJ2uj_w38BIGF1VQ</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Hadjiargyrou, Michael</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202211</creationdate><title>Effects of bisphosphonates on appendicular fracture repair in rodents</title><author>Hadjiargyrou, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-3fa9a24f58e2b130806df48dbb17079a4cd41ed5fb8d088fb3c08160591eb2903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bisphosphonates</topic><topic>Fracture repair</topic><topic>Osteoporosis</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hadjiargyrou, Michael</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bone (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hadjiargyrou, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of bisphosphonates on appendicular fracture repair in rodents</atitle><jtitle>Bone (New York, N.Y.)</jtitle><date>2022-11</date><risdate>2022</risdate><volume>164</volume><spage>116542</spage><epage>116542</epage><pages>116542-116542</pages><artnum>116542</artnum><issn>8756-3282</issn><eissn>1873-2763</eissn><abstract>The balance between osteoclastic bone resorption and osteoblastic bone formation is ultimately responsible for maintaining a structural and functional skeleton. Despite their strength, bones do break and the main cause of fractures are trauma and decreased bone mineral density as a result of aging and/or pathology that weakens the bone's microarchitecture and subsequently, its material properties. Osteoporosis is a disease marked by increased osteoclast activity and decreased osteoblastic activity tipping the remodeling balance in favor of bone resorption and can be caused by aging, glucocorticoids, disuse and estrogen-deficiency. Ultimately, this leads to brittle and weaker bones which become more prone to trauma or stress-induced fractures. The current treatment for preventing and treating osteoporotic fractures is the use of antiresorptive drugs such as bisphosphonates (BPs) and denosumab, but unfortunately, their long-term use, especially with alendronate and ibandronate, has been associated with increased risk of atypical femoral fractures (AFFs); femoral diaphyseal fractures distal to the lesser trochanter but proximal to the supracondylar flare. The purpose of this review is to examine the information that exists in the literature examining the effects of BPs on fracture repair of long bones in rodent (rat and mouse) models. The focus on rodents stems from the scientific community's unresolved need to develop small animal models to examine the molecular, cellular, tissue and biomechanical mechanisms responsible for the development of AFFs and how best they can be treated. •Osteoporosis is a major health care problem.•Long-term use of bisphosphonates has been associated with increased risk of atypical femoral fractures (AFFs).•Multiple rat and mouse studies have been conducted with bisphosphonates and fracture repair.•Results of bisphosphonate use during fracture repair are mixed; some show benefits while other do not.•There is a need for additional studies in small animal models in order to study AFFs.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.bone.2022.116542</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 8756-3282
ispartof Bone (New York, N.Y.), 2022-11, Vol.164, p.116542-116542, Article 116542
issn 8756-3282
1873-2763
language eng
recordid cdi_proquest_miscellaneous_2708735764
source Elsevier ScienceDirect Journals
subjects Bisphosphonates
Fracture repair
Osteoporosis
Rodents
title Effects of bisphosphonates on appendicular fracture repair in rodents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T23%3A06%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20bisphosphonates%20on%20appendicular%20fracture%20repair%20in%20rodents&rft.jtitle=Bone%20(New%20York,%20N.Y.)&rft.au=Hadjiargyrou,%20Michael&rft.date=2022-11&rft.volume=164&rft.spage=116542&rft.epage=116542&rft.pages=116542-116542&rft.artnum=116542&rft.issn=8756-3282&rft.eissn=1873-2763&rft_id=info:doi/10.1016/j.bone.2022.116542&rft_dat=%3Cproquest_cross%3E2708735764%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2708735764&rft_id=info:pmid/&rft_els_id=S8756328222002198&rfr_iscdi=true